Literature DB >> 7917906

Inhibition of the regulation of intracellular pH: potential of 5-(N,N-hexamethylene) amiloride in tumour-selective therapy.

J Luo1, I F Tannock.   

Abstract

The viability of cells within the acidic microenvironment found in solid tumours is expected to depend on the regulation of intracellular pH (pHi). 5-(N,N-hexamethylene) amiloride (HMA) is a potent inhibitor of the Na+/H+ antiport, a major mechanism for the regulation of pHi. We have therefore studied the cytotoxicity of HMA in combination with nigericin, a cell-acidifying agent, for EMT-6 cells in monolayer cell culture, in spheroids and in a murine tumour model. The combination of nigericin and HMA was toxic to cells in tissue culture at extracellular pH (pHe) < or = 6.8 (as may be found in tumours) but not at pH 7.0 or above (as in most normal tissues). Compared with amiloride, the relative potency of HMA in causing in vitro cytotoxicity (approximately 100-fold) was similar to that for inhibition of the Na+/H+ antiport. The fluorescent probe Hoechst 33342 was used with flow cytometry to study the cytotoxicity of HMA and nigericin at different depths in multicellular tumour spheroids. Only small differences in the level of cell survival were observed, but higher concentrations of HMA were required as compared with those giving equal levels of survival in monolayer culture. The pharmacokinetics of HMA in mice was studied by using high-performance liquid chromatography: after intraperitoneal injection of 20 micrograms g-1, the plasma level of HMA peaked at 8 microM after about 15 min and decreased to 1 microM at 120 min; the half-life was 35 min. Nigericin and HMA, at doses of 1.25 micrograms g-1 and 10 micrograms g-1 respectively, failed to cause significant cell killing in the EMT-6 murine tumour, but the surviving fraction was reduced to approximately 0.004 when hydralazine was administered with nigericin and HMA. Local tumour irradiation (15 Gy), followed by treatment with these drugs, led to cell killing that was additive to the effects of drugs and radiation alone, so that hypoxic cells which survived radiation did not appear more sensitive to pH-dependent drug treatment. Acid-mediated therapy can lead to cell death in murine solid tumours, but further measures will be required before the strategy can be exploited clinically.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917906      PMCID: PMC2033413          DOI: 10.1038/bjc.1994.360

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

Review 1.  Metabolic regulation via intracellular pH.

Authors:  W B Busa; R Nuccitelli
Journal:  Am J Physiol       Date:  1984-04

2.  Influences of growth conditions and cell-cell contact on responses of tumor cells to ultrasound.

Authors:  P G Sacks; M W Miller; R M Sutherland
Journal:  Radiat Res       Date:  1981-07       Impact factor: 2.841

3.  Increased radioresistance of cells in cultured multicell spheroids. I. Dependence on cellular interaction.

Authors:  H Dertinger; D Hülser
Journal:  Radiat Environ Biophys       Date:  1981       Impact factor: 1.925

4.  Pyrazine diuretics. II. N-amidino-3-amino-5-substituted 6-halopyrazinecarboxamides.

Authors:  E J Cragoe; O W Woltersdorf; J B Bicking; S F Kwong; J H Jones
Journal:  J Med Chem       Date:  1967-01       Impact factor: 7.446

5.  Blockade of the Na+/H+ antiport abolishes growth factor-induced DNA synthesis in fibroblasts. Structure-activity relationships in the amiloride series.

Authors:  G L'Allemain; A Franchi; E Cragoe; J Pouysségur
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

6.  Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro.

Authors:  R E Durand
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

7.  Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditions.

Authors:  M J Boyer; I F Tannock
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

8.  Blood flow modification in the SCCVII tumor: effects of 5-hydroxytryptamine, hydralazine, and propranolol.

Authors:  C E Peters; D J Chaplin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

9.  Cytoplasmic pH and free Mg2+ in lymphocytes.

Authors:  T J Rink; R Y Tsien; T Pozzan
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

10.  Effects of agents which inhibit the regulation of intracellular pH on murine solid tumours.

Authors:  K Newell; P Wood; I Stratford; I Tannock
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

View more
  10 in total

1.  6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.

Authors:  Benjamin J Buckley; Ashraf Aboelela; Elahe Minaei; Longguang X Jiang; Zhihong Xu; Umar Ali; Karen Fildes; Chen-Yi Cheung; Simon M Cook; Darren C Johnson; Daniel A Bachovchin; Gregory M Cook; Minoti Apte; Mingdong Huang; Marie Ranson; Michael J Kelso
Journal:  J Med Chem       Date:  2018-09-07       Impact factor: 7.446

Review 2.  Structure-Activity Relationship of Benzofuran Derivatives with Potential Anticancer Activity.

Authors:  Joviana Farhat; Lara Alzyoud; Mohammad Alwahsh; Basem Al-Omari
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

Review 3.  Disrupting proton dynamics and energy metabolism for cancer therapy.

Authors:  Scott K Parks; Johanna Chiche; Jacques Pouysségur
Journal:  Nat Rev Cancer       Date:  2013-09       Impact factor: 60.716

4.  6-Substituted amiloride derivatives as inhibitors of the urokinase-type plasminogen activator for use in metastatic disease.

Authors:  Benjamin J Buckley; Hiwa Majed; Ashraf Aboelela; Elahe Minaei; Longguang Jiang; Karen Fildes; Chen-Yi Cheung; Darren Johnson; Daniel Bachovchin; Gregory M Cook; Mingdong Huang; Marie Ranson; Michael J Kelso
Journal:  Bioorg Med Chem Lett       Date:  2019-10-28       Impact factor: 2.823

5.  BI-1 enhances Fas-induced cell death through a Na+/H+-associated mechanism.

Authors:  Geum-Hwa Lee; Hyung-Ryong Kim; Han-Jung Chae
Journal:  BMB Rep       Date:  2014-07       Impact factor: 4.778

6.  The p90rsk-mediated signaling of ethanol-induced cell proliferation in HepG2 cell line.

Authors:  Han Sang Kim; Su-Jin Kim; Jinhyung Bae; Yiyi Wang; Sun Young Park; Young Sil Min; Hyun Dong Je; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2016-10-28       Impact factor: 2.016

7.  Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.

Authors:  Scott K Parks; Yann Cormerais; Jerome Durivault; Jacques Pouyssegur
Journal:  Oncotarget       Date:  2017-02-07

8.  The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies.

Authors:  Anastasia L Berg; Ashley Rowson-Hodel; Michelle Hu; Michael Keeling; Hao Wu; Kacey VanderVorst; Jenny J Chen; Jason Hatakeyama; Joseph Jilek; Courtney A Dreyer; Madelyn R Wheeler; Ai-Ming Yu; Yuanpei Li; Kermit L Carraway
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.575

9.  Repeated administration of inhibitors for ion pumps reduce markedly tumor growth in vivo.

Authors:  Igor Hrgovic; Zeljko Glavic; Zeljko Kovacic; Smaila Mulic; Lejla Zunic; Zlatko Hrgovic
Journal:  Med Arch       Date:  2014

10.  Screening of 5- and 6-Substituted Amiloride Libraries Identifies Dual-uPA/NHE1 Active and Single Target-Selective Inhibitors.

Authors:  Benjamin J Buckley; Ashna Kumar; Ashraf Aboelela; Richard S Bujaroski; Xiuju Li; Hiwa Majed; Larry Fliegel; Marie Ranson; Michael J Kelso
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.